Navigation Links
Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

LEXINGTON, Massachusetts, June 11, 2013 /PRNewswire/ --

Shire's Chief Financial Officer, Graham Hetherington will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12th at 9:20 AM PT /17:20 BST. Investors may access a live audio webcast of the presentation at


Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

For further information please contact:

Investor Relations:

Souheil Salah,, +44-1256-894160

Erin K. Kelly,, +1-781-482-9541

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
2. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
3. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
4. Shire Reaches Agreement in Principle With U.S. Government
5. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. Shire Changes its NASDAQ Ticker Symbol to SHPG
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
10. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
11. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
Breaking Biology News(10 mins):